A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.

Source:http://linkedlifedata.com/resource/pubmed/id/17293705

Download in:

View as

General Info

PMID
17293705